Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice: The role of Nrf2/HO-1/NQO1 and HMGB1/RAGE/TLR4/NFκB pathways.

Abstract

BACKGROUND:

Epilepsy is a severe neurological disorder associated with substantial morbidity and mortality. Vanillin (Van) is a natural phenolic aldehyde with beneficial pharmacological properties. This study investigated the neuroprotective effects of Van in epilepsy and elucidated its mechanism of action.

METHODS:

Swiss albino mice were divided into the following five groups: "normal group", 0.9 % saline; "pentylenetetrazole (PTZ) group", intraperitoneal administration of 35 mg/kg PTZ on alternate days up to 42 days; and "PTZ + Van 20", "PTZ + Van 40", and "PTZ + sodium valproate (Val)" groups received PTZ injections in conjunction withVan 20 mg, Van 40 mg/kg, and Val 300 mg/kg, respectively. Behavioural tests and hippocampal histopathological analysis were performed in all groups. The Nrf2/HO-1/NQO1 and HMGB1/RAGE/TLR4/NFκB pathways, oxidative stress, neuro-inflammation, and apoptotic markers were analysed. Furthermore, brain acetylcholinesterase (AChE) activity and levels of dopamine (DA), gamma-aminobutyric acid GABA, and serotonin 5-HT were assessed.

RESULTS:

Van prolonged seizure manifestations and improved electroencephalogram (EEG)criteriain conjunction with 100 mg/kg PTZ once daily. Van administration increased Nrf2/HO-1/NQO1 levels, with subsequent attenuation of malondialdehyde (MDA) and nitric oxide (NO) levels with elevated glutathione (GSH) levels and intensified superoxide dismutase (SOD) and catalase activities. Van reduced the gene and protein expression of HMGB1/RAGE/TLR4/NFκB and decreased the levels of inflammatory and apoptotic markers. In addition, Van reduced AChE activity, and elevated glial fibrillary acidic proteins (GFAP) increased neurotransmitter and brain-derived neurotrophic factors (BDNF).

CONCLUSION:

By increasing Nrf2/HO-1/NQO1 levels and downregulating the HMGB1/RAGE/TLR4/ NFκB pathway, Van offered protection in PTZ-kindled mice with subsequent attenuation in lipid peroxidation, upregulation in antioxidant enzyme activities, and reduction in inflammation and apoptosis.

• Authors: Mervt M Almostafa, Maged E Mohamed, Nancy S Younis
• Journal: International immunopharmacology (Int Immunopharmacol) Vol. 129 Pg. 111657 (Mar 10 2024) ISSN: 1878-1705 [Electronic] Netherlands
• PMID: 38335655 (Publication Type: Journal Article)
• Copyright: Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Chemical References

• Pentylenetetrazole
• NF-E2-Related Factor 2
• vanillin
• Toll-Like Receptor 4
• HMGB1 Protein
• Acetylcholinesterase
• Antioxidants
• Glutathione
• Benzaldehydes

Topics

• Mice
• Animals
• Pentylenetetrazole
• NF-E2-Related Factor 2 (metabolism)
• Toll-Like Receptor 4 (metabolism)
• HMGB1 Protein (metabolism)
• Acetylcholinesterase (metabolism)
• Epilepsy (chemically induced)
• Antioxidants (therapeutic use, metabolism)
• Oxidative Stress
• Memory Disorders
• Glutathione (metabolism)
• Inflammation
• Benzaldehydes